News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
487,204 Results
Type
Article (8017)
Company Profile (141)
Press Release (479046)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166738)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52875)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238192)
Policy (17898)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (8)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (494)
Accelerated approval (27)
ADA (18)
Adcomms (1)
Allergies (100)
Alliances (33156)
ALS (115)
Alzheimer's disease (991)
Antibody-drug conjugate (ADC) (305)
Approvals (10444)
Artificial intelligence (351)
ASCO (160)
Autoimmune disease (232)
Automation (32)
Bankruptcy (263)
Belgium (3)
Best Places to Work (6957)
BIO (36)
Biologics (24)
BIOSECURE Act (1)
Biosimilars (122)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (8)
Bladder cancer (140)
Brain cancer (34)
Breast cancer (527)
Cancer (3878)
Cardiovascular disease (234)
Career advice (245)
Career pathing (1)
CAR-T (184)
CDC (1)
CDMO (25)
Celiac Disease (3)
Cell therapy (502)
Cervical cancer (36)
Clinical research (48282)
Collaboration (1330)
Commercialization (17)
Compensation (1596)
Complete response letters (35)
COVID-19 (764)
CRISPR (66)
C-suite (836)
Cystic fibrosis (88)
Data (6147)
Denatured (4)
Depression (108)
Dermatology (91)
Diabetes (375)
Diagnostics (4239)
Digital health (40)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (167)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (172)
Earnings (73810)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88445)
Executive appointments (726)
Eye disease (3)
FDA (12605)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (1)
Friedreich's ataxia (19)
Frontotemporal dementia (25)
Funding (986)
Gene editing (129)
Generative AI (13)
Gene therapy (343)
GLP-1 (304)
Government (948)
Grass and pollen (2)
Guidances (281)
Healthcare (9376)
Hematology (94)
HIV (55)
Huntington's disease (24)
Idiopathic pulmonary fibrosis (5)
IgA nephropathy (72)
Immunology and inflammation (111)
Immuno-oncology (64)
Indications (172)
Infectious disease (962)
Inflammatory bowel disease (135)
Inflation Reduction Act (4)
Influenza (87)
Intellectual property (269)
Interviews (41)
IPO (12393)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (17)
Kidney disease (62)
Layoffs (59)
Legal (5195)
Licensing (35)
Liver cancer (46)
Longevity (22)
Lung cancer (560)
Lung diease (8)
Lymphoma (263)
Machine learning (29)
Management (3)
Manufacturing (601)
Marketing (12)
MASH (120)
Medical affairs (2)
Medical device (8702)
Medtech (8875)
Mergers & acquisitions (14438)
Metabolic disorders (754)
mRNA (70)
Multiple sclerosis (110)
Multispecific (1)
NASH (4)
Netherlands (1)
Neurodegenerative disease (235)
Neuropsychiatric disorders (40)
Neuroscience (1912)
Neurotech (1)
NextGen: Class of 2026 (3150)
Non-profit (843)
Obesity (236)
Opinion (10)
Ovarian cancer (174)
Pain (184)
Pancreatic cancer (220)
Parkinson's disease (214)
Partnered (12)
Patents (520)
Patient advocacy (2)
Patient recruitment (541)
Patient selection (29)
Peanut (33)
People (41455)
Peptides (11)
Pharmaceutical (30)
Pharmacy benefit managers (10)
Phase 1 (15584)
Phase 2 (21565)
Phase 3 (14556)
Pipeline (8132)
Policy (18)
Postmarket research (1570)
Preclinical (6574)
Press Release (34)
Prostate cancer (199)
Psychedelics (10)
Radiopharmaceuticals (201)
Rare diseases (614)
Real estate (3024)
Recruiting (6)
Regenerative medicine (10)
Regulatory (15108)
Reports (23)
Research institute (590)
Resumes & cover letters (45)
Rett syndrome (45)
RNA editing (8)
RSV (49)
Schizophrenia (108)
Series A (172)
Series B (126)
Service/supplier (5)
Sickle cell disease (64)
Spinal muscular atrophy (92)
Sponsored (5)
Startups (2021)
Stem cells (1)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (53)
Vaccines (343)
Venture capital (17)
Weight loss (76)
Wet AMD (1)
Women's health (94)
Date
Today (87)
Last 7 days (342)
Last 30 days (1481)
Last 365 days (19176)
2026 (14841)
2025 (19251)
2024 (22987)
2023 (26538)
2022 (34587)
2021 (37167)
2020 (33468)
2019 (23256)
2018 (17468)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (230)
Alabama (80)
Alaska (2)
Arizona (315)
Arkansas (12)
Asia (18013)
Australia (2114)
California (12677)
Canada (3321)
China (562)
Colorado (516)
Connecticut (441)
Delaware (219)
Europe (24753)
Florida (1909)
Georgia (400)
Hawaii (3)
Idaho (46)
Illinois (753)
India (57)
Indiana (330)
Iowa (17)
Japan (444)
Kansas (104)
Kentucky (33)
Louisiana (27)
Maine (27)
Maryland (1255)
Massachusetts (8296)
Michigan (319)
Minnesota (587)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (128)
New Hampshire (60)
New Jersey (2784)
New Mexico (12)
New York (2979)
North Carolina (1344)
North Dakota (4)
Northern California (6404)
Ohio (301)
Oklahoma (14)
Oregon (16)
Pennsylvania (2358)
Puerto Rico (24)
Rhode Island (30)
South America (407)
South Carolina (80)
South Dakota (1)
Southern California (5279)
Tennessee (128)
Texas (2088)
United States (41092)
Utah (384)
Vermont (1)
Virginia (162)
Washington D.C. (39)
Washington State (975)
West Virginia (1)
Wisconsin (81)
Wyoming (1)
487,204 Results for "pharmazz inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pharmazz, Inc. Receives U.S. FDA IND Clearance to Initiate Phase 3 Clinical Trial of Sovateltide in Traumatic Brain Injury
September 30, 2026
·
7 min read
Press Releases
Pharmazz Completes Enrollment in 160-Patient Phase 4 Trial of Sovateltide in Acute Ischemic Stroke
September 28, 2026
·
4 min read
Press Releases
Pharmazz, Inc. Receives U.S. FDA Orphan Drug Designation for Sovateltide for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy (NHIE)
September 14, 2026
·
3 min read
Press Releases
Pharmazz, Inc. Appoints Ajay Bansal as Chief Financial Officer
May 14, 2026
·
4 min read
Press Releases
Pharmazz Presents Positive Phase IV Interim Analysis of Sovateltide for Acute Ischemic Stroke at the International Stroke Conference 2026
February 4, 2026
·
2 min read
Press Releases
Pharmazz Inc. Announces Enrollment of First Patient in Phase 3 Clinical Trial of Sovateltide for Treating Patients with Cerebral Ischemic Stroke
July 30, 2025
·
5 min read
Business
Pharmazz Inc. and Dr. Reddy’s Laboratories have entered into a licensing agreement to market Centhaquine (Lyfaquin) as a resuscitative agent for hypovolemic shock in India
Pharmazz, Inc. (“Pharmazz”), a biopharmaceutical company developing and commercializing drug products to treat critically ill patients, announced that it has entered into a license agreement with Dr. Reddy’s Laboratories Limited (“Dr. Reddy’s”), a global pharmaceutical company, to commercialize a first-in-class innovative drug Centhaquine in India.
March 22, 2024
·
5 min read
Press Releases
Pharmazz Inc. and Sun Pharma entered into an agreement under which Sun Pharma will invest up to $15 Million in Pharmazz, Inc.
August 21, 2024
·
4 min read
BioMidwest
Pharmazz, Inc. Announces Marketing Approval of Sovateltide in India for Acute Cerebral Ischemic Stroke Patients
Pharmazz, Inc. (“Pharmazz” or the “Company”), a biopharmaceutical company focused on developing and commercializing novel therapeutics to treat patients in critical care, announced that The Directorate General of Health Services, India on May 31st, 2023, granted the manufacture and marketing of Sovateltide Injection for cerebral ischemic stroke patients.
May 31, 2023
·
2 min read
Press Releases
Pharmazz Inc. announces that Dr. Neil Marwah has joined the Company as its President
September 11, 2024
·
6 min read
1 of 48,721
Next
